Ramipril Capsule
Product Images NDC 50090-1120

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 50090-1120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500901118)

Label for Ramipril 5 mg capsules by A-S Medication Solutions. The label includes dosage strength (5 mg), storage instructions (store at 68 to 77 degrees Fahrenheit), quantity (30 capsules), and a note that each hard gelatin capsule contains Ramipril USP 5 mg. The label also shows lot number and NDC 50090-1118-0.*

FDA Label Image

Label Image (Lbl500901120)

Ramipril 10 mg capsule label from A-S Medication Solutions. The label states storage instructions to keep at 68 to 77 degrees Fahrenheit and package contains 30 capsules. It includes dosing instructions and barcode information, along with the National Drug Code (NDC) 50090-1120-0.*

FDA Label Image

Ramipril Fig1

A line graph comparing the proportion of patients over days of follow-up between Ramipril and Placebo groups. The x-axis represents days of follow-up up to about 1600 days, and the y-axis shows the proportion of patients up to 0.20. Ramipril shows a consistently lower proportion of patients compared to Placebo, with a significance indicator P=0.0001.*

FDA Label Image

Ramipril Fig2

A forest plot chart showing relative risk in the Ramipril group with 95% confidence intervals across various patient subgroups. The chart lists subgroups by conditions such as cardiovascular disease, diabetes, age, sex, hypertension, myocardial infarction history, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. It includes the number of patients and incidence of composite outcomes in the placebo group for each subgroup.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure diagram of the active ingredient Ramipril, showing its molecular composition and arrangement as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.